Long-term persistence of cellular hyporesponsiveness to filarial antigens after clearance of microfilaremia

American Journal of Tropical Medicine and Hygiene

Volumn 60, Issue 5, 1999, Pages 848-853

  Gopinath, Ramya ^a   Hanna, L Elizabeth ^b   Kumaraswami, V ^b   Pillai, S V Perumal ^c   Kavitha, V ^c   Vijayasekaran, V ^c   Rajasekharan, Annabelle ^c   Nutman, Thomas B ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^c MADRAS MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLCARBAMAZINE; GAMMA INTERFERON; IVERMECTIN;

ARTICLE; CELL ACTIVITY; CLINICAL ARTICLE; DISEASE ACTIVITY; ERADICATION THERAPY; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; INTERFERON PRODUCTION; MALE; MICROFILARIA; MICROFILARIASIS; PARASITE CONTROL; PARASITEMIA; WUCHERERIA BANCROFTI;

EID: 0032903768     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.60.848     Document Type: Article

References (39)

1. Mahanty S, Nutman TB, 1995. Immunoregulation in human lymphatic filariasis: the role of interleukin 10. Parasite Immunol 17: 385-392.
2. Sartono E, Kruize YCM, Partono F, Kurniawan A, Maizels RM, Yazdanbakhsh M, 1995. Specific T cell unresponsiveness in human filariasis: diversity in underlying mechanisms. Parasite Immunol 17: 587-594.
3. Nutman TB, Kumaraswami V, Ottesen EA, 1987. Parasite-specific anergy in human filariasis. J Clin Invest 79: 1516-1523.
4. Piessens WF, McGreevy PB, Piessens PW, Koiman J, Saroso JS, Dennis DT, 1980. Immune responses in human infections with Brugia malayi. Specific cellular unresponsiveness to filarial antigens. J Clin Invest 65: 172-179.
5. Dimock KA, Eberhard ML, Lammie PJ, 1996. Th1-like antifilarial immune responses predominate in antigen-negative persons. Infect Immun 64: 2962-2967.
6. Ramsdell F, Fowlkes BJ, 1992. Maintenance of in vivo tolerance by persistence of antigen. Science 343: 890-893.
7. Steel C, Guinea A, McCarthy JS, Ottesen EA, 1994. Long-term effect of prenatal exposure to maternal microfilaremia on immune responsiveness to filarial parasite antigens. Lancet 343: 890-893.
8. Osborne J, Hunter SJ, Devaney E, 1996. Anti-interleukin-4 modulation of the Th2 polarized response to the parasite nematode Brugia pahangi. Infect Immun 64: 3461-3466.
9. de Almeida AB, Maia e Silva MC, Maciel MA, Freedman DO, 1996. The presence or absence of active infection, not clinical status, is most closely associated with cytokine responses in lymphatic filariasis. J Infect Dis 173: 1453-1459.
10. Sartono E, Kruize YCM, Kurniawan A, Maizels RM, Yazdanbakhsh M, 1996. In Th2-biased lymphatic filarial patients, responses to purified protein derivative of Mycobacterium tuberculosis remain Th1. Eur J Immunol 26: 501-504.
11. Lammie PJ, Eberhard ML, Leiva LE, Lowrie RC, Katz SP, 1988. The effect of diethylcarbamazine treatment of bancroftian filariasis on the immunological reactivity of microfilaremic individuals. Trans R Soc Trop Med Hyg 82: 726-729.
12. Lammie PJ, Hightower AW, Richards FO, Bryan RT, Spencer HC, McNeeley DF, McNeeley MB, Eberhard ML, 1992. Alterations in filarial antigen-specific immunologic reactivity following treatment with ivermectin and diethylcarbamazine. Am J Trop Med Hyg 46: 292-295.
13. Piessens WF, Ratiwayanto S, Piessens PW, Tuti S, McGreevy PB, Darwis F, Palmieri JR, Koiman I, Dennis DT, 1981. Effect of treatment with diethylcarbamazine on immune responses to filarial antigens in patients infected with Brugia malayi. Acta Trop 38: 227-234.
14. Ottesen EA, Weller PF, Heck L, 1977. Specific cellular immune responsiveness in human filariasis. Immunology 33: 413-421.
15. Sartono E, Kruize YCM, Kurniawan A, vander Meide PH, Partono F, Maizels RM, Yazdanbakhsh M, 1995. Elevated cellular immune responses and interferon-γ release after long-term diethylcarbamazine treatment of patients with human lymphatic filariasis. J Infect Dis 171: 1683-1687.
16. Kitchen LW, 1995. Diethylcarbamazine-related immunity (letter). J Infect Dis 172: 1639-1640.
17. Medina-dela Garza CE, Brattig NW, Tischendorf FW, Jarrett JMB, 1990. Serum-dependent interaction of granulocytes with Onchocerca volvulus microfilariae in generalized and chronic hyper-reactive onchocerciasis and its modulation by diethyl-carbamazine. Trans R Soc Trop Med Hyg 84: 701-706.
18. + human T cells in vitro. J Immunol 160: 351-360.
19. Hartmann S, Kyewski B, Sonnenburg B, Lucius R, 1997. A filarial cysteine protease inhibitor down-regulates T cell proliferation and enhances interleukin-10 production. Eur J Immunol 27: 2253-2260.
20. del Prete G, de Carli M, Almerigogna F, Grazia Giudizi M, Biagiotti R, Romagnani S, 1993. Human IL-10 is produced by both type 1 helper (Th1) and type 2 (Th2) cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 150: 353-360.
21. Mahanty S, Luke HE, Kumaraswami V, Narayanan PR, Vijayshekaran V, Nutman TB, 1996. Stage-specific induction of cytokines regulates the immune response in lymphatic filariasis. Exp Parasitol 84: 282-290.
22. Mahanty S, Mollis SN, Ravichandran M, Abrams JS, Kumaraswami V, Jayaraman K, Ottesen EA, Nutman TB, 1996. High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis. J Infect Dis 173: 769-773.
23. Allen JE, Lawrence RA, Maizels RM, 1996. APC from mice harbouring the filarial nematode, Brugia malayi, prevent cellular proliferation but not cytokine production. Int Immunol 8: 143-151.
24. King CL, Mahanty S, Kumaraswami V, Abrams JS, Regunathan J, Jayaraman K, Ottesen EA, Nutman TB, 1993. Cytokine control of parasite-specific anergy in human lymphatic filariasis. J Clin Invest 92: 1667-1673.
25. + cells after chemotherapy in human Schistosoma haematobium infection. Eur J Immunol 26: 1365-1370.
26. Greene BM, Fanning MM, Ellner JJ, 1983. Non-specific suppression of antigen-induced lymphocyte blastogenesis in Onchocerca volvulus infection in man. Clin Exp Immunol 52: 259-265.
27. Steel C, Lujan-Trangay A, Gonzalez-Peralta C, Zea-Flores G, Nutman TB, 1991. Immunologic responses to repeated ivermectin treatment in patients with onchocerciasis. J Infect Dis 164: 581-587.
28. Steel C, Lujan-Trangay A, Gonzalez-Peralta C, Zea-Flores G, Nutman TB, 1994. Transient changes in cytokine profiles following ivermectin treatment of onchocerciasis. J Infect Dis 170: 962-970.
29. Soboslay PT, Dreweck CM, Hoffmann WH, Luder CG, Heuschkel C, Gorgen H, Banla M, Schulz-Key H, 1992. Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment. Clin Exp Immunol 89: 407-413.
30. Luty AJF, Downham MD, Whitworth JAG, Morgan D, Taylor DW, 1992. Immunological studies on onchocerciasis in Sierra Leone. 2. Cell-mediated responses after repeated treatment with ivermectin. Trop Med Parasitol 43: 54-58.
31. Vanamail P, Subramanian S, Das PK, Pani SP, Rajagopalan PK, Bundy DAP, Grenfeld BT, 1989. Estimation of age-specific rates of acquisition and loss of Wuchereria bancrofli infection. Trans R Soc Trop Med Hyg 83: 689-693.
32. Steel C, Nutman TB, 1993. Regulation of IL-5 in onchocerciasis: the critical role for 1L-2. J Immunol 150: 5511-5518.
33. Sartono E, Kruize YC, Kurniawan A, Maizels RM, Yazdanbakhsh M, 1997. Depression of antigen-specific interleukin-5 and interferon-γ responses in human lymphatic filariasis as a function of clinical status and age. J Infect Dis 175: 1276-1280.
34. Cooper PJ, Guderian RH, Nutman TB, Taylor DW, 1997. Human infection with Onchocerca volvulus does not affect the T helper cell phenotype of the cellular immune response to mycobacterial antigen. Trans R Soc Trop Med Hyg 91: 350-352.
35. Kazura J, Greenberg J, Perry R, Weil G, Day K, Alpers M, 1993. Comparison of single-dose diethylcarbamazine and ivermectin for treatment of bancroftian filariasis in Papua New Guinea. Am J Trop Med Hyg 49: 804-811.
36. Dreyer G, Coutinho A, Miranda D, Noroes J, Rizzo JA, Galdino E, Rocha A, Medeiros Z, Andrade LD, Santos A, Figueredo-Silva J, Ottesen EA, 1995. Treatment of bancroftian filariasis in Recife, Brazil: a two-year comparative study of the efficacy of single treatments with ivermectin or diethylcarbamazine. Trans R Soc Trop Med Hyg 89: 98-102.
37. Cao W, vander Ploeg C, Plaisier AP, vander Sluijs IJ, Habbema JDF, 1997. Ivermectin for the chemotherapy of bancroftian filariasis: a meta-analysis of the effect of single treatment. Trop Med Int Health 4: 393-403.
38. Moulia-Pelat JP, Glaziou P, Weil G, Nguyen LN, Gaxotte P, Nicolas L, 1995. Combination ivermectin plus diethylcarbamazine, a new effective tool for control of lymphatic filariasis. Trop Med Parasitol 46: 9-12.
39. Ottesen EA, Duke BO, Karam M, Behbehani K, 1997. Strategies and tools for the control/ elimination of lymphatic filariasis. Bull World Health Organ 75: 491-503.